These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. Hansen BR; Petersen J; Haugaard SB; Madsbad S; Obel N; Suzuki Y; Andersen O HIV Med; 2009 Jul; 10(6):378-87. PubMed ID: 19490178 [TBL] [Abstract][Full Text] [Related]
23. Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. Uccelli MC; Torti C; Lapadula G; Labate L; Cologni G; Tirelli V; Moretti F; Costarelli S; Quiros-Roldan E; Carosi G Ann Nutr Metab; 2006; 50(3):247-52. PubMed ID: 16508252 [TBL] [Abstract][Full Text] [Related]
24. Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance. Vayá A; Rivera L; Hernández-Mijares A; de la Fuente M; Solá E; Romagnoli M; Alis R; Laiz B Clin Hemorheol Microcirc; 2012; 52(1):49-56. PubMed ID: 22460264 [TBL] [Abstract][Full Text] [Related]
25. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F; AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566 [TBL] [Abstract][Full Text] [Related]
26. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project. Björck J; Hellgren M; Råstam L; Lindblad U Metabolism; 2006 Aug; 55(8):1007-13. PubMed ID: 16839834 [TBL] [Abstract][Full Text] [Related]
27. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients. Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P; J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723 [TBL] [Abstract][Full Text] [Related]
28. Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients. Domingo P; Gallego-Escuredo JM; Domingo JC; Gutiérrez Mdel M; Mateo MG; Fernández I; Vidal F; Giralt M; Villarroya F AIDS; 2010 Nov; 24(17):2629-37. PubMed ID: 20935553 [TBL] [Abstract][Full Text] [Related]
29. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy. Falutz J Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086 [TBL] [Abstract][Full Text] [Related]
30. [Plasma homocysteine in human immunodeficiency virus infected patient]. de Larrañaga G; Alonso B; Puga L; Benetucci J Medicina (B Aires); 2003; 63(5):393-8. PubMed ID: 14628648 [TBL] [Abstract][Full Text] [Related]
31. Lipodystrophy - a sign for metabolic syndrome in patients of the HIV-HEART study. Potthoff A; Brockmeyer NH; Gelbrich G; Neuhaus K; Esser S; Reinsch N; Hower M; Mostardt S; Neumann A; Neumann T; J Dtsch Dermatol Ges; 2010 Feb; 8(2):92-8. PubMed ID: 20002869 [TBL] [Abstract][Full Text] [Related]
32. The metabolic syndrome, an epidemic among HIV-infected patients on HAART. Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676 [TBL] [Abstract][Full Text] [Related]
33. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients. Catena C; Colussi G; Nait F; Capobianco F; Sechi LA Am J Hypertens; 2015 Jul; 28(7):943-50. PubMed ID: 25498997 [TBL] [Abstract][Full Text] [Related]
34. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nigam A; Frasure-Smith N; Lespérance F; Julien P Nutr Metab Cardiovasc Dis; 2009 May; 19(4):264-70. PubMed ID: 18804984 [TBL] [Abstract][Full Text] [Related]
35. Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. Bianchi G; Nicolino F; Passerini G; Grazi GL; Zappoli P; Graziani R; Berzigotti A; Chianese R; Mantovani V; Pinna AD; Zoli M Liver Transpl; 2006 Jan; 12(1):105-11. PubMed ID: 16382457 [TBL] [Abstract][Full Text] [Related]
36. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment. Crook M Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292 [TBL] [Abstract][Full Text] [Related]
37. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand. Lee B; Aurpibul L; Sirisanthana V; Mangklabruks A; Sirisanthana T; Puthanakit T HIV Med; 2009 Feb; 10(2):72-8. PubMed ID: 19018877 [TBL] [Abstract][Full Text] [Related]
38. HIV lipodystrophy and its metabolic consequences: implications for clinical practice. Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641 [TBL] [Abstract][Full Text] [Related]
39. The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia. Huang CW; Chen TH; Lin HS; Tseng YL; Lai SL; Chen WH; Chen SS; Liu JS Acta Neurol Taiwan; 2007 Jun; 16(2):81-5. PubMed ID: 17685131 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study. Squillace N; Lapadula G; Torti C; Orlando G; Mandalia S; Nardini G; Beghetto B; Costarelli S; Guaraldi G HIV Med; 2008 Mar; 9(3):151-9. PubMed ID: 18218000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]